Filing Details

Accession Number:
0001562180-19-000338
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-01-17 16:58:19
Reporting Period:
2019-01-15
Accepted Time:
2019-01-17 16:58:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1100412 Array Biopharma Inc ARRY Pharmaceutical Preparations (2834) 841460811
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1714982 Gale Curtis Oltmans C/O Array Biopharma, 3200 Walnut St.
Boulder CO 80301
General Counsel No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-01-15 19,720 $8.94 23,641 No 4 M Direct
Common Stock Disposition 2019-01-15 19,720 $18.06 3,921 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2019-01-15 19,720 $0.00 19,720 $8.94
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
430,280 2027-08-15 No 4 M Direct
Footnotes
  1. These trades were made pursuant to a Rule 10b5-1 trading plan.
  2. The price reported for these shares is the weighted average sale price of transactions made at prices from $18.00 to $18.17. Details of actual prices for shares sold are available from the Issuer upon request.
  3. The option vests in four equal annual installments beginning August 15, 2018.